Our Take

Strengthening Pharmacy Reimbursement

20 Minute Read

    Health system reimbursement for provider-administered medications is at risk. Many health systems are already writing off substantial medication-related revenue because of ineffective management of medication prior authorizations and denials.

    Two current trends further elevate the potential for significant financial losses on provider-administered medications. First, payers are increasing restrictions on which patients and drugs can be infused in hospital-based infusion settings. Second, rising drug prices and a growing pipeline of high-cost specialty medications mean the impact of each medication denial is increasingly expensive.

    To mitigate both present and imminent financial challenges from medication-related denials, health system finance and pharmacy leaders must partner together to strengthen pharmacy revenue cycle processes.

    Log in to access this content

    Log in

    Don't have an account? Learn about membership benefits

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.